Search Results for: LUNA
Plus, the investment opportunities behind Biden's electric transportation push.
Published:
Spectrum Pharmaceuticals announced good news for lung cancer patients in its midstage trial on Tuesday.
Published:
Bristol-Myers Squibb shares dipped on Tuesday after the company reported results from its late-stage lung cancer study.
Published:
Last Updated:
Either the market does not believe that Best Buy’s (NYSE: BBY) new CEO Hubert Joly, former head of hotel operator Carlson, can turn the consumer electronics retailer around, or fears have grown...
Published:
Clovis shares might not be showing it now, but the company is facing some heat from the SEC over charges of misleading investors about the company’s developmental lung cancer drug.
Published:
Last Updated:
Merrimack Pharmaceuticals shares dropped early on Friday after the company announced that it would be terminating its midstage SHERLOC study in patients with non-small cell lung cancer.
Published:
Last Updated:
Merck saw its shares make a handy gain on Tuesday after it reported that a late-stage trial of Keytruda met its dual primary endpoints.
Published:
Last Updated:
It is no secret that pharma and biotech shares have had to deal with at least some headwinds over the past year. It turns out that drug pricing concerns and political oversight can still be...
Published:
Last Updated:
One of the biggest surprises in Latin America these days is news that Brazil’s financial community is increasingly optimistic about the continent’s biggest economy.
Published:
Source: Courtesy of 20th Century FoxThe Star Wars franchise is back! The Walt Disney Company (NYSE: DIS) is acquiring Lucasfilm Ltd. from George Lucas. The deal is a cash and stock transaction...
Published:
Last Updated:
Shares of Imclone Systems Inc. (NASDAQ:IMCL) are screaming higher this morning on it meeting its primary endpoint of increasing survival in its Phase III lung cancer studies. Imclone and...
Published:
Last Updated:
Lung cancer may have just met a new standard of care. On top of that, it would be considered a new standard as a first line of care in lung cancer and longer overall survival rates.
Published:
Last Updated:
When companies see their shares rise by 100% or more in a single day, it's usually because of a buyout or an extremely positive change in a company's future prospects. For Genprex, it was a nod from...
Published:
Binance's CEO has suggested that the crypto exchange could allow LUNC users to ”opt-in for a 1.2% trading fee themselves for burn” instead of forcing them to do so in a tweet.
Published: